FDA Inspection 1101140 — Regenerative Biologics, Inc.
The FDA completed an inspection of Regenerative Biologics, Inc. on July 12, 2019 in Palm City, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 12, 2019
- Fiscal Year
- 2019
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Palm City, FL (United States)